NCT05082597View on ClinicalTrials.gov

Clinical Outcome of Extracorporeal Shock Wave Therapy in Patient With Axillary Web Syndrome

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 13, 2021

Primary Completion Date

March 31, 2025

Study Completion Date

March 31, 2025

Conditions
Axillary Web SyndromeBreast CancerLymphedemaExtracorporeal Shock Wave Therapy
Interventions
DEVICE

Low energy ESWT

Therapeutic sessions: 4(once a week, for 4 weeks) Total dosage: 2500 shoots over axillary cord lesion (1000 over most fibrotic area, 500 over upper arm, 500 over forearm, 500 over other area) Energy: 0.056-0.065mJ/mm2

Trial Locations (1)

407219

Taichung Veterans General Hospital, Taichung

All Listed Sponsors
lead

Taichung Veterans General Hospital

OTHER

NCT05082597 - Clinical Outcome of Extracorporeal Shock Wave Therapy in Patient With Axillary Web Syndrome | Biotech Hunter | Biotech Hunter